‘Historic’ New Funding Mechanism To Boost African Vaccine Production
Up to $1bn in incentive and milestone payments is to be offered to manufacturers over a 10-year period, focusing on priority antigens and diseases.
Up to $1bn in incentive and milestone payments is to be offered to manufacturers over a 10-year period, focusing on priority antigens and diseases.